Appco Pharma LLC FDA Record
- Latest inspection VAI · May 14, 2026
- No warning letters matched by name
Appco Pharma LLC has 6 FDA recalls, 14 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Appco Pharma LLC" is on file.
- Latest recall
- D-0421-2026 · Class II · Mar 27, 2026
- Latest inspection
- May 14, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 14 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Appco Pharma LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 3 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 2 | 0 |
| 2019 | 2 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Appco Pharma LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Appco Pharma LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0421-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon… | Mar 27, 2026 |
| D-0419-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon… | Mar 27, 2026 |
| D-0420-2026 | Class II | Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon… | Mar 27, 2026 |
| D-0208-2025 | Class III | Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC… | Jan 16, 2025 |
| D-0649-2020 | Class II | Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC… | Jan 7, 2020 |
| D-0648-2020 | Class II | Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC… | Jan 7, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 14, 2026 | Piscataway, NJ | Drugs | Voluntary Action Indicated (VAI) | 3010014758 |
| Mar 11, 2024 | Piscataway, NJ | Drugs | Voluntary Action Indicated (VAI) | 3010014758 |
| Aug 29, 2023 | Piscataway, NJ | Drugs | Voluntary Action Indicated (VAI) | 3010014758 |
| Aug 19, 2022 | Piscataway, NJ | Drugs | Voluntary Action Indicated (VAI) | 3010014758 |
| Mar 27, 2020 | Piscataway, NJ | Drugs | No Action Indicated (NAI) | 3010014758 |
| May 28, 2019 | Piscataway, NJ | Drugs | No Action Indicated (NAI) | 3010014758 |
| Apr 15, 2019 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3008793007 |
| Nov 6, 2018 | Piscataway, NJ | Drugs | Voluntary Action Indicated (VAI) | 3010014758 |
| Jun 27, 2016 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3008793007 |
| Jun 27, 2016 | Piscataway, NJ | Drugs | No Action Indicated (NAI) | 3010014758 |
| Aug 21, 2014 | Piscataway, NJ | Drugs | No Action Indicated (NAI) | 3010014758 |
| Aug 21, 2014 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3008793007 |
| Jan 16, 2014 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3008793007 |
| Dec 22, 2011 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3008793007 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3010014758 | Piscataway, NJ | 9 | May 14, 2026 |
| FEI 3008793007 | Somerset, NJ | 5 | Apr 15, 2019 |
Appco Pharma LLC and the FDA: common questions
Has Appco Pharma LLC received an FDA warning letter?
No FDA warning letter addressed to the name "Appco Pharma LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Appco Pharma LLC received an FDA Form 483?
FDA has not published a Form 483 for "Appco Pharma LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Appco Pharma LLC?
The most recent FDA inspection on file ended May 14, 2026 at Piscataway, NJ and was classified VAI. FDA has 14 inspections of Appco Pharma LLC on file.
Has Appco Pharma LLC had an FDA recall?
Yes. Appco Pharma LLC has 6 FDA recalls on record. The most recent started Mar 27, 2026.
Need more than this page shows? Ask about Appco Pharma LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.